Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients

Joanne S. L. Lim; Xiang A. Chen; Onkar Singh; Yoon S. Yap; Raymond C. H. Ng; Nan S. Wong; Mabel Wong; Edmund J. D. Lee; Balram Chowbay

首页> 外文期刊>British Journal of Clinical Pharmacology >Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients

【24h】

Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients

机译：CYP2D6，CYP3A5，CYP2C9和CYP2C19多态性对亚洲乳腺癌患者他莫昔芬药代动力学的影响

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT

机译：关于此主题的已知知识

著录项

来源
《British Journal of Clinical Pharmacology》 |2011年第5期|737-750|共14页
作者
Joanne S. L. Lim; Xiang A. Chen; Onkar Singh; Yoon S. Yap; Raymond C. H. Ng; Nan S. Wong; Mabel Wong; Edmund J. D. Lee; Balram Chowbay;
展开▼
作者单位

Laboratory of Clinical Pharmacology Division of Medical Sciences Humphrey Oei Institute of Cancer Research;

Department of Medical Oncology National Cancer Centre;

Department of Pharmacology Yong Loo Lin School of Medicine National University of Singapore Singapore;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
CYP2C19; CYP2D6; CYP3A5; pharmacogenetics; pharmacokinetics; tamoxifen;

机译：CYP2C19;CYP2D6;CYP3A5;药物遗传学;药代动力学;他莫昔芬;

相似文献

外文文献
中文文献
专利

1. Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients. [J] . Lim JS, Chen XA, Singh O, British Journal of Clinical Pharmacology . 2011,第5期

机译：CYP2D6，CYP3A5，CYP2C9和CYP2C19多态性对亚洲乳腺癌患者他莫昔芬药代动力学的影响。
2. Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients [J] . Joanne S. L. Lim, Xiang A. Chen, Onkar Singh, British journal of clinical pharmacology . 2011,第5期

机译：CYP2D6，CYP3A5，CYP2C9和CYP2C19基因多态性对亚洲乳腺癌患者他莫昔芬药代动力学的影响
3. 553 The influence of {CYP2D6} and {CYP3A5} pharmacogenetics on pharmacokinetics of tamoxifen and its metabolites in Asian breast cancer patients [J] . B. Chowbay, J.S.L. Lim, O. Singh, European Journal of Cancer Supplements . 2010,第7期

机译：553 {CYP2D6 }和 {CYP3A5 }药物遗传学对他莫昔芬及其代谢物在亚洲乳腺癌患者中药代动力学的影响
4. CYP2D6, GYP2C19, CYP2C9 and CYP3A5 polymorphism in the Spanish population [C] . Llovo R., Tudoli I., Carril J.C, International Conference on Alzheimer's and Parkinson's Diseases . 2009

机译：CYP2D6，GYP2C19，CYP2C9和CYP3A5在西班牙语人群中的多态性
5. Melatonin-Tamoxifen Drug Conjugates as Breast Cancer Drugs: Pharmacological Evaluation in Phenotypically Diverse Breast Cancer Models and Pharmacokinetic Assessment in Liver Microsome and Female Mouse Models [D] . Hasan, Mahmud. 2020

机译：褪黑激素 - 西昔芬药物缀合物作为乳腺癌药物：在肝微粒和女性小鼠模型中表型多种乳腺癌模型和药代动力学评估的药理评估
6. Impact of CYP2D6 CYP3A5 CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients [O] . Joanne S L Lim, Xiang A Chen, Onkar Singh, 2011

机译：CYP2D6CYP3A5CYP2C9和CYP2C19多态性对亚洲乳腺癌患者他莫昔芬药代动力学的影响
7. Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients [O] . Lim, Joanne S L, Chen, Xiang A, Singh, Onkar, 2011

机译：CYP2D6，CYP3A5，CYP2C9和CYP2C19多态性对他莫昔芬药代动力学在亚洲乳腺癌患者中的影响

Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients

摘要

著录项

相似文献

相关主题

期刊订阅